References
- Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007;22:1999–2009.
- Koff SA. Requirements for accurately diagnosing chronic partial upper urinary tract obstruction in children with hydronephrosis. Pediatr Radiol. 2008;38(1):S41–S48.
- Woodward M, Frank D. Postnatal management of antenatal hydronephrosis. BJU Int. 2002;89:149–156.
- Wühl E, van Stralen KJ, Verrina E, et al. Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol. 2013;8:67–74.
- Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:127–132.
- Roth L, Koncina E, Satkauskas S, et al. The many faces of semaphorins: from development to pathology. Cell Mol Life Sci. 2009;66:649–666.
- Behar O, Golden JA, Mashimo H, et al. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature. 1996;383:525–528.
- Villegas G, Tufro A. Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney. Mech Dev. 2002;119(1):S149–S153.
- Robert B, Zhao X, Abrahamson DR. Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am J Physiol Renal Physiol. 2000;279:F275–F282.
- Jayakumar C, Ranganathan P, Devarajan P, et al. Semaphorin 3A is a new early diagnostic biomarker of experimental and pediatric acute kidney injury. PLoS One. 2013;8:e58446.
- Mohamed R, Ranganathan P, Jayakumar C, et al. Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice. J Mol Med (Berl). 2014;92:1245–1256.
- Ranganathan P, Jayakumar C, Mohamed R, et al. Semaphorin 3A inactivation suppresses ischemia-reperfusion-induced inflammation and acute kidney injury. Am J Physiol Renal Physiol. 2014;307:F183–F194.
- Viazzi F, Ramesh G, Jayakumar C, et al. Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study. J Nephrol. 2015;28:315–320.
- Serafini T, Kennedy TE, Galko MJ, et al. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell. 1994;78:409–424.
- Cirulli V, Yebra M. Netrins: beyond the brain. Nat Rev Mol Cell Biol. 2007;8:296–306.
- Ly NP, Komatsuzaki K, Fraser IP, et al. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci USA. 2005;102:14729–14734.
- Ramesh G. Role of Netrin-1 beyond the brain: from biomarker of tissue injury to therapy for inflammatory diseases. Recent Pat Biomark. 2012;2:202–208.
- Wang W, Reeves WB, Ramesh G. Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol. 2008;294:F739–F747.
- Ramesh G, Krawczeski CD, Woo JG, et al. Urinary Netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2010;5:395–401.
- Reeves WB, Kwon O, Ramesh G. Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury. Am J Physiol Renal Physiol. 2008;294:F731–F738.
- Braga LH, Ruzhynsky V, Pemberton J, et al. Evaluating practice patterns in postnatal management of antenatal hydronephrosis: a national survey of Canadian pediatric urologists and nephrologists. Urology. 2014;83:909–914.
- Williams B, Tareen B, Resnick MI. Pathophysiology and treatment of ureteropelvic junction obstruction. Curr Urol Rep. 2007;8:111–117.
- Ingraham SE, McHugh KM. Current perspectives on congenital obstructive nephropathy. Pediatr Nephrol. 2011;26:1453–1461.
- Nguyen HT, Herndon CD, Cooper C, et al. The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol. 2010;6:212–231.
- Piepsz A. Antenatal detection of pelviureteric junction stenosis: main controversies. Semin Nucl Med. 2011;41:11–19.
- Tondeur M, De Palma D, Roca I, et al. Inter-observer reproducibility in reporting on renal drainage in children with hydronephrosis: a large collaborative study. Eur J Nucl Med Mol Imaging. 2008;35:644–654.
- Malki M, Linton KD, Mackinnon R, et al. Conservative management of pelvi-ureteric junction obstruction (PUJO): is it appropriate and if so what duration of follow-up is needed? BJU Int. 2012;110:446–448.
- Josephson S. Antenatally detected, unilateral dilatation of the renal pelvis: a critical review. 1. Postnatal non-operative treatment 20 years on–is it safe? Scand J Urol Nephrol. 2002;36:243–250.
- Ramesh G, Kwon O, Ahn K. Netrin-1: a novel universal biomarker of human kidney injury. Transplant Proc. 2010;42:1519–1522.
- Tu Y, Wang H, Sun R, et al. Urinary Netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Ren Fail. 2014;36:1559–1563.
- Grenz A, Dalton JH, Bauerle JD, et al. Partial Netrin-1 deficiency aggravates acute kidney injury. PLoS One. 2011;6:e14812.
- Wang W, Reeves WB, Pays L, et al. Netrin-1 overexpression protects kidney from ischemia reperfusion injury by suppressing apoptosis. Am J Pathol. 2009;175:1010–1018.
- Wang W, Reeves WB, Ramesh G. Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor. Am J Physiol Renal Physiol. 2009;296:F723–F729.